00:22:56 EDT Thu 28 May 2020
Enter Symbol
or Name

Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 142,663,825
Close 2019-03-15 C$ 3.94
Recent Sedar Documents

Emerald Health appoints VP, comm, stakeholder relations

2019-03-18 08:08 ET - News Release

Mr. Rob Hill reports


Allan Rewak has been appointed vice-president, communications and stakeholder relations, of Emerald Health Therapeutics Inc. effective April 15, 2019.

Prior to joining Emerald, Mr. Rewak was the executive director at the Cannabis Council of Canada (C3), Canada's national industry association for cannabis, cultivators and processors. In the role, he unified multiple industry associations into one collective and navigated the sector through the successful legalization of adult-use cannabis. For his work, the Financial Post named him "One of the 20 Power Players Setting Down Roots in the Cannabis Industry."

Mr. Rewak also served as director of communications and stakeholder relations at Newstrike Resources, a partner at Pathway Group, and a consultant at Leonard Domino & Associates.

"We are pleased to welcome Allan to the Emerald team," said Dr. Avtar Dhillon, executive chairman and president of Emerald. "His deep industry relationships and proven experience in the sector, combined with his strong background in communications and stakeholder relations with all major relevant sectors of the industry, are expected to augment our existing capabilities."

Mr. Rewak has been granted an option to acquire up to 150,000 common shares vesting over a three-year period.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a Canadian licensed producer of cannabis. Its 50-per-cent-owned Pure Sunfarms joint venture in British Columbia is completing the conversion of its 1.1-million-square-foot (25-acre) greenhouse for cannabis cultivation in the Lower Mainland and its Verdelite operation in Quebec is completing the buildout of its 88,000-square-foot indoor cultivation facility.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.